Literature DB >> 3350042

Endothelium-dependent relaxation in estrogen-treated spontaneously hypertensive rats.

S P Williams1, D P Shackelford, S G Iams, S J Mustafa.   

Abstract

Female spontaneously hypertensive rats (SHR) were injected subcutaneously with mestranol twice a week for 12 weeks. Isolated segments of thoracic aorta were then used to generate relaxation response curves to acetylcholine or ATP after precontraction with phenylephrine. Estrogen treatment attenuated the development of hypertension. Further, augmented endothelium-dependent relaxation to acetylcholine was seen in the estrogen-treated SHR. There was no difference, however, in the relaxation produced by ATP. Since the relaxation of both acetylcholine and ATP is endothelium-dependent, these findings suggest that different mechanisms may be involved in the relaxation produced by acetylcholine and ATP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350042     DOI: 10.1016/0014-2999(88)90231-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

Review 1.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

Review 2.  Cardiovascular pharmacology of hormone replacement therapy.

Authors:  G M Rosano; G Panina
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

3.  Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and s-nitrosylation in mouse aorta.

Authors:  Hyehun Choi; Rita C Tostes; R Clinton Webb
Journal:  J Cardiovasc Pharmacol       Date:  2011-11       Impact factor: 3.105

Review 4.  Sexual dimorphism in rodent models of hypertension and atherosclerosis.

Authors:  Kristen J Bubb; Rayomand S Khambata; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.